PRME position history
The shares of Prime Medicine (PRME) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 1,500,000 shares, $11M, 0.05% of portfolio, New
- 2024 Q2: 750,000 shares, $3.9M, 0.02% of portfolio, Reduce −50.0%
- 2024 Q3: 750,000 shares, $2.9M, 0.01% of portfolio
- 2024 Q4: 750,000 shares, $2.2M, 0.01% of portfolio
- 2025 Q1: 750,000 shares, $1.5M, <0.01% of portfolio
- 2025 Q2: 750,000 shares, $1.9M, <0.01% of portfolio
- 2025 Q3: 9,500,000 shares, $53M, 0.22% of portfolio, Add +1166.7%
- 2025 Q4: 1,240,843 shares, $4.3M, 0.02% of portfolio, Reduce −86.9%
- 2026 Q1: 1,240,843 shares, $4.3M, 0.02% of portfolio
- 2026 Q2: 1,240,843 shares, $4.6M, 0.02% of portfolio
- 2026 Q3: 1,240,843 shares, $3.8M, 0.02% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|